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1. Introduction
Attempts to develop synthetic vascular grafts for the replacement of diseased vascular sec‐
tions have been an area of active research over the past decades [1]. However, thrombosis
formation as a result of platelet adhesion to the luminal surface of synthetic graft and reste‐
nosis caused by host inflammatory remain a challenge, especially for small-diameter (<6
mm) graft replacement [2,3]. Therefore, the haemocompatibility of the biomaterial used in
the graft is a prerequisite for clinical success. As the result, various strategies have been de‐
veloped to improve the blood compatibility of biomaterial surfaces, including the surface
immobilization of anti-coagulants such as heparin [4] and sulfated silk fibroin [5], the incor‐
poration of polyethylene oxide or negatively charged side chains [6,7], and surface passiva‐
tion with protein layers, such as albumin [8]. Despite the efficacy of these approaches in
preventing acute thrombogenesis, concerns remain on the drug elution lifespan, with possi‐
ble consequence of late thrombosis [9]. To avoid undesirable blood-material interaction, the
seeding of autologous endothelial cells (ECs) onto the luminal surface of the graft is consid‐
ered to be an ideal approach to increase the patency of synthetic grafts [10]. Many studies
have indicated that endothelial cells release factors that regulate thrombogenesis and plate‐
let activation [11], while delayed or absent stent endothelialization has been implicated in
late thrombosis and adverse clinical outcomes [13]. Thus, rapid endothelialization of vascu‐
lar grafts is of great importance for blood-contacting vessels for long-term patency.
Due to its slow degradation rates in vivo (2-4 years) [14], good mechanical strength, and bio‐
compatibility with vascular cell types [15,16], polycaprolactone (PCL) is currently being ex‐
© 2013 Yuan et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
tensively investigated as scaffolds for vascular tissue engineering applications [17-21].
However, the intrinsic hydrophobicity and poor cytocompatibility of PCL substrates lead to
poor affinity for cell adhesion, thereby restricting their applications as blood-contacting de‐
vices. Consequently, surface modification of PCL is necessary to improve cell adhesion and
proliferation. Functional polymer brushes containing reactive hydroxyl (-OH), carboxyl (-
COOH) or amine (-NH2) groups have been successfully grafted onto the PCL surfaces using
γ-ray irradiated, ozone or photo-induced polymerization grafting to introduce hydrophilici‐
ty [9,16,22-24]. These flexible reactive groups on the polymer brushes are well-suited to con‐
jugate bioactive macromolecules for improved cytocompatibility. However, γ-ray
irradiated, ozone or photo-induced polymerization grafting of polymer brushes has several
limitations, including low density of grafting due to steric hindrance, uncontrollable graft
yield of polymer brushes, and undesired formation of a covalent bond between reactive
groups on the polymer brushes and the surface [25]. Hence, an alternative grafting approach
that allows control over brush density, polydispersity and composition is desired.
One such alternative is the use of surface-initiated atom transfer radical polymerization
(ATRP) approach to covalently graft polymer brushes in a tunable and controllable manner
[26]. This approach allows the preparation of well-defined dense polymer brushes contain‐
ing reactive pendant groups (e.g. -OH, -COOH, or epoxide groups), and provides highly re‐
active binding sites for functional biomolecules.[27] As a result, surface-initiated ATRP
provides a promising approach to fabricate PCL substrates with well-defined polymer
brushes of controlled length and density, as well as tunable grafting density of biomacromo‐
lecules. However, to the best of our knowledge, only few studies have been devoted to mod‐
ifying biodegradable polyester polymers using surface-initiated ATRP to improve their
cytocompatibility or blood compatibility [27,28]. Also, the functionality of the attached cells
was not thoroughly investigated in those studies.
As such, the aim of the current study is to utilize the surface-initiated ATRP method to tailor
PCL substrates with dense functional P(GMA) brushes and high-density immobilized gela‐
tin to improve their properties for cell attachment and proliferation. Each functionalization
step was ascertained by XPS, AFM and water contact angle measurements. The cytocompat‐
ibility of the functionalized PCL substrates was evaluated using human umbilical vein en‐
dothelial cells (HUVECs) and the effect of different surface properties on the regulation of
the thrombogenicity of the attached cells was also investigated.
2. Materials and methods
2.1. Materials
Polycaprolactone pellets (PCL, average Mn45000), 1,6-hexanediamine (98%), glycidyl metha‐
crylate (GMA, >97%), 2-bromoisobutyrl bromide (BIBB, 98%), 2,2'-bipyridine (bpy, 98%), di‐
chloromethane (anhydrous, >99.8%), triethylamine (TEA, 98%), isopropyl alcohol,  hexane
(anhydrous, >95%), copper (I) bromide (CuBr, 99%), copper (II) bromide (CuBr2, 98%), and
gelatin (Porcine skin, Type A) were obtained from Sigma-Aldrich Chemical Co. (St. Louis,
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MO, USA), and were used without further purification. GMA was passed through a silica gel
column to remove the inhibitor, and stored under a nitrogen atmosphere at -4oC. All the other
chemical reagents and solvents were used as received. Human Umbilical Vein Endothelial
cells (HUVECs, ATCC CRL-1730TM) were purchased from American Type Culture Collection
(Manassas, VA, USA). Cell culture medium (MCDB131), heparin and paraformaldehyde (4%,
v/v) were obtained from Sigma-Aldrich Chemical Co. Medium supplements, such as Foetal
Bovine Serum (FBS), penicillin, amphotericin, bovine brain extract, streptomycin, and Tryp‐
sin-EDTA (0.25%),  were  purchased  from Life  Technologies  (Carlsbad,  CA,  USA).  LIVE/
DEAD®  cell viability assay reagent, AlamarBlueTM  reagent, tissue thromboplastin (human
brain extract), ellagic acid, and DAF-FM Diacetatewere obtained from Life Technologies. The
P-selectin assay reagents were obtained from Serotec Co. (Kidlington, Oxford, UK).
2.2. Aminolysis of PCL film substrates and immobilization of ATRP initiator
Polycaprolactone (PCL) films were prepared by solution casting method using previously
established methods [29]. Briefly, 5 g of the PCL pellets was dissolved in 40 ml of dichloro‐
methane to form the PCL solution. The polymer solution was then cast onto the glass sub‐
strate with predetermined thickness using the automatic film applicator (PA-2105, BYK).
The solvent was removed at room temperature by slow evaporation over a 24 h period, and
was further dried in a vacuum oven for another 24 h at 35 oC to obtain the translucent PCL
films with a thickness of about 150 μm. The resultant PCL films were cut into round-shaped
specimens with a diameter of 2 cm. The activation of PCL substrates was performed by ami‐
nolysis treatment using a procedure previously described [30,31]. Briefly, the PCL films
were immersed in a 10% (w/w) 1,6-hexanediamine and isopropanol mixture at 40 oC for a
predetermined time. After aminolysis treatment, the resultant PCL-NH2 surfaces were thor‐
oughly rinsed with copious amounts of deionized water and isopropanol, respectively, to
remove free 1,6-hexanediamine, and dried in a vacuum oven at 30 oC for 24 h.
The introduction of an alkyl halide ATRP initiator on the PCL-NH2 surface was accomplish‐
ed through the reaction of the amino groups with 2-bromoisobutyrate bromide (BIBB) [32].
The PCL-NH2 films were immersed in 30 ml of anhydrous hexane solution containing 1.0 ml
(7.2 mmol) of triethylamine (TEA). After 30 min of degassing with nitrogen, the reaction
mixture was cooled in an ice bath, and 0.89 ml (1.65g, 7.2 mmol) of BIBB was added drop‐
wise via a syringe. The reaction was allowed to proceed with gentle stirring at 0 oC for 2 h
and then at room temperature for 12 h. The resulting surface (referred to as the PCL-Br sur‐
face) was washed thoroughly with copious amounts of hexane, ethanol, and finally deion‐
ized water, in that order, and was subsequently dried in a vacuum oven under reduced
pressure at ambient temperature overnight.
2.3. Surface-initiated ATRP of GMA and immobilization of gelatin
For the grafting of P(GMA) brushes from the PCL-Br surfaces, surface-initiated ATRP of
GMA was performed using a [GMA (3 ml)]:[CuBr]:[CuBr2]:[Bpy] molar feed ratio of
100:1.0:0.2:2.0 in 5 ml of methanol/water mixture (5/1, v/v) at room temperature in a Pyrex®
tube. The reaction was allowed to proceed for 0.5 to 3 h to produce the PCL-g-P(GMA) sur‐
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faces. After the prescribed reaction time, the films were removed and washed sequentially
with copious amount of methanol and deionized water, followed by immersing in methanol
for about 48 h to ensure the complete removal of the physically-adsorbed reactants or poly‐
mers. For the immobilization of gelatin onto the pendant epoxide groups of the P(GMA)
brushes, the PCL-g-P(GMA) films were incubated in 10 ml of the phosphate buffered saline
(PBS, pH 7.4) containing 3 mg/ml gelatin. The reaction was allowed to proceed at room tem‐
perature for 24 h under continuous stirring to produce the corresponding PCL-g-P(GMA)-c-
gelatin surfaces. After the reaction, the gelatin-immobilized PCL films were washed
thoroughly with PBS solution and deionized water to remove the physically adsorbed (re‐
versibly-bound) gelatin, prior to being dried in a vacuum oven under reduced pressure
overnight.
2.4. Grafting density of the P(GMA) brushes and immobilized gelatin
The grafting density of the P(GMA) brushes and the amount of immobilized gelatin on the
PCL substrates was determined by the grafting yield (GY) using the following equation
[27,33]:
a bW WGY A
-= (1)
Where Wa and Wb are the weights of the dry film after and before graft polymerization (or
immobilization of gelatin) respectively, and A is the film area (about 3.2 cm2). For each GY
measurement, a minimum of three pieces of PCL films was used and the resulting values
were averaged.
2.5. Surface characterization
The composition of the functionalized PCL films was determined by X-ray photoelectron
spectroscopy (XPS). All the XPS spectra were recorded on a Krato AXIS Hsi spectrometer
with a monochromatic Al Kα X-ray source (1486.6 eV photons), using procedures similar to
those described previously [32]. The N 1s core-level signal can be used as an indicator of the
immobilized gelatin. The [N]/[C] ratio, as determined from the sensitivity-factor-corrected N
1s and C 1s core-level XPS spectral area, indicated the relative abundance of the immobi‐
lized gelatin on the PCL substrates. Static water contact angles of the functionalized PCL
film surfaces were measured at 25 oC and 60% relative humidity using a sessile drop method
with 3 μl water droplets on a FTÅ 200 contact angle goniometer (First Ten Angstroms Inc.,
Portsmouth, VA, USA). The contact angles reported were the mean values from four sub‐
strates, with the value of each substrate obtained by averaging the contact angles for at least
three surface locations. The surface topography of the functionalized PCL substrates was in‐
vestigated by atomic force microscope (AFM). A multimode scanning probe microscope
equipped with a NanoscopeIIIa controller (Digital Instrument, Santa Barbara, USA) was
used to capture the AFM images in air. 10 μm scans were recorded in tapping mode with a
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silicon cantilever. The drive amplitude was about 300 mV, and the scan rate was between 0.5
and 1.0 Hz. The arithmetic mean of the surface roughness (Ra) was determined by Nano‐
scope software.
2.6. Cytocompatibility of the functionalized PCL substrates
Human umbilical vein endothelial cells (HUVECs, ATCC CRL-1730TM) were cultured in gel‐
atin-coated T25 flasks containing MCDB131 cell culture medium supplemented with Foetal
Bovine Serum, 0.2% Bovine Brain Extract, 0.25 ug/ml amphotericin, 0.1 mg/ml heparin, 100
U/ml penicillin, and 100 ug/ml streptomycin, in a CO2 environment at 37oC. The MCDB131
medium was changed every other day. Upon 90% culture confluency, cells were harvested
by trypsinization using 0.25% Trypsin-EDTA. ECs between 4-6 passages were used for sub‐
sequent experiments.
2.6.1. Cell proliferation
The pristine and functionalized PCL films were sterilized by immersing into 75% (v/v) etha‐
nol solution for 60 min, and then rinsed thrice with sterile PBS, followed by MCDB131 medi‐
um incubation overnight. Gelatin-coated coverslips (0.1%) were used as positive controls.
Cell viability and proliferation was determined using the AlamarBlueTM(AB) assay. 0.5 ml of
EC cell suspension (2×104 cells/ml) was seeded into each well of 24-well plate containing the
pristine and functionalized PCL films, and incubated in a 5% CO2 environment at 37 oC for
1, 3, 5 and 7 days. The cell culture medium was changed every other day. After the predeter‐
mined incubation period, culture media was removed from the wells, and 0.5 ml of the AB
solution (10% AB solution in culture media without FBS) was added to the wells. The plates
were incubated in a 5% CO2 atmosphere at 37ºC for 4 h and the fluorescence density was
measured using a microplate reader (Model 680, Bio-Rad Laboratories, Inc. Hercules, CA,
USA) at an excitation wavelength of 570 nm and an emission wavelength of 580 nm. Cell
numbers were calculated using standards derived from seeding known quantities of cells
and correlating with fluorescence emission.
2.6.2. Cell imaging
In vitro qualitative analysis of cell coverage and viability was performed using a LIVE/
DEAD® viability/cytotoxicity assay to assess the extent of endothelialization on the function‐
alized PCL surfaces. For this procedure, calcein AM (4 mM in anhydrous dimethyl sulfox‐
ide, DMSO) and EthD-1 (2 mM in DMSO/H2O, 1:4 v:v) were added to PBS (1:1000 ratio) to
produce a LIVE/DEAD® staining solution. The cell-seeded PCL samples, obtained after 7
days cell culture, were first washed thrice with PBS to eliminate the nonadherent cells, fol‐
lowed by staining using 0.1 ml of LIVE/DEAD staining solution. After incubation in a 5%
CO2 atmosphere at 37oC for 30 min, the samples were visualized by Nikon Image Ti fluores‐
cence microscope (emission at 515 nm and 635 nm (Nikon Instruments, Tokyo, Japan) to ac‐
quire fluorescent images using NIS-Elements Br software.
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2.7. Blood compatibility of the bare and endothelialized PCL substrates
The hemolysis rate, coagulant activity, nitric oxide (NO) production, and platelet activation
of the bare and endothelialized PCL films with various surface functionalizations were in‐
vestigated to evaluate their blood compatibility. The endothelialized PCL substrates were
obtained by culturing ECs (2×104 cells/ml) for 7 days on surface-functionalized PCL films us‐
ing the procedures described above.
2.7.1. Hemolysis rate test
The pristine and functionalized PCL samples were immersed in diluted blood solution con‐
taining 2% fresh anticoagulated (ACD) human blood and 98% physiological salt solution
and incubated at 37o for 1 h. After centrifugation at 3000 rpm for 5 min, the absorbance of
solution was recorded as Dt. Under the same conditions, the solution containing 2% ACD
blood and 98% physiological salt solution was used as a negative reference, and the solution
containing 2% ACD blood and 98% distilled water was used as a positive reference. These
absorbances were recorded as Dnc and Dpc, respectively. The hymolysis rate α of the samples
was calculated using the following equation:
α = Dt - DncDpc - Dnc ×100% (2)
2.7.2. Coagulation assays
Whole blood of healthy human volunteers was mixed with 3.8% sodium citrate at a volume
ratio of 1:9. The blood was centrifuged at 3000 rpm for 15 min at room temperature to obtain
platelet-poor plasma (PPP). Aliquots of 500 μl of PPP were added to be in contact with the
surfaces of each bare or endothelialized PCL substrate for 10 min at 37oC. The PPP was then
collected and added with tissue thromboplastin (human brain extract) for prothrombin time
(PT) tests, or added with a partial thromboplastin reagent (ellagic acid) for activated partial
thromboplastin time (APTT) test. Subsequently, the fibrin clot formation time was deter‐
mined by an automatic coagulation analyzer (Sysmex CA-7000). PPP that was not exposed
to the PCL substrates was used as a blank sample.
2.7.3. Nitric Oxide (NO) secretion by HUVEC
ECs cultured for 7 days on the functionalized PCL substrates were washed twice with PBS
and incubated at 37oC with trypsin-EDTA (0.25%) solution for cell detachment. The resul‐
tant ECs were serum-starved overnight in serum-free medium. After incubation with fresh
serum-free medium for 6 h, the medium was removed and DAF-FM diacetate (Molecular
Probes, D-23842) was added to the medium to effect a final concentration of 10 μM.The me‐
dium was subsequently incubated at 37 °C for 1 h, followed by detection of fluorescence us‐
ing Glomax 20/20 luminometer equipped with a blue fluorescent module. The end product
of DAF-FM diacetate and NO is a benzotriazole derivative with a fluorescence excitation
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and emission maxima of 495 and 515 nm, respectively. Fluorescence units were normalized
to cell numbers.
2.7.4. Platelet activation determination by P-selectinassay
Platelet activation by the bare and endothelialized PCL substrates was investigated using
the P-selectin (CD62P) assay. Briefly, 100 μl of fresh human platelet rich plasma (PRP) was
incubated with the bare or 7-day endothelialized PCL substrates at 37oC for 2 h. At the end
of incubation, the films were thoroughly with copious amounts of PBS solution thrice, fol‐
lowed by adding 40 μl of anti-CD62P (1:100, v:v) to each film, and then incubated at 37oC for
1 h. After being washed thrice with PBS solution, the films were each incubated with 40 μl
of horseradish peroxidase-conjugated sheep anti-mouse polycolonal antibody at 1:100 (v:v)
at 37oC for 1 h. Subsequently, the PCL films were reacted with 150 μl of 3,3',5, 5'-tetrame‐
thylbenzidine (TMB) chromogenic solution for 10 min. The color reaction was terminated by
adding of 100 μL of 1 M H2SO4, and the optical densities (OD) were measured at 450 nm
using a Varioskan Flash Microplate Reader (Thermo Fisher Scientific, Waltham, MA, USA).
2.7.5. Gene and protein expression of vWF and activity of MMP-2 in ECs cultured on functionalized
PCL surfaces
For the real-time qPCR of von Willebrand factor (vWF) and matrix metalloproteinase-2
(MMP-2), the total RNA was extracted from the ECs after 7 days in culture, reverse-transcri‐
bed into cDNA and analyzed as described above. The expression of vWF and MMP-2 was
normalized to the housekeeping ribosomal protein L27 (rpl27). Endothelial cells treated with
10 ng /ml TNF were used as positive controls.
For the immunoblot detection of vWF protein, cells were lyzed in protein lysis buffer (0.1%
sodium dodecyl sulfate, 0.5% triton X-100, and 0.5% sodium deoxycholate dissolved in pH
7.4 PBS) and resolved using a denaturing 10% SDS-PAGE. The proteins were then blotted
onto a nitrocellulose membrane and after blocking with 5% non-fat milk in tris-buffered sal‐
ine with 0.1% Tween (TBS-T), the membrane stained using a rabbit anti-human vWF anti‐
body at 1:5000 and subsequently with anti-rabbit HRP-conjugated antibody at 1:10,000 in
TBS-T. The vWF was then visualized after developing using chemiluminescence on X-ray
film. For determination of the MMP-2 activity, proteins were extracted from trypsinized
cells using the protein lysis buffer before resolving by electrophoresis through a 10% SDS-
PAGE copolymerized with 0.1% gelatin as substrate for enzymatic digestion. The molecular
sizes of gelatinolytic activities were determined using protein standards (Fermentas, Pre-
stained PAGE rulers). Upon completion of gel running, the gel was incubated with 100 mL
renaturation buffer containing 2.5% triton X-100 for 1 h at room temperature with agitation.
The gel was subsequently incubated in 100 ml of development buffer containing 50 mM Tris
base, 200 mM NaCl, 5 mM CaCl2, and 0.02% Brij-35 overnight at 37 °C. Developed gel was
then stained by the Coomassie Blue and gelatinolytic activities of MMP-2 were determined
by the transparent bands appeared at the molecular weight of approximately 68 kDa and 98
kDa, respectively.
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2.8. Statistical analysis
Each experiment was carried out with four replicates (n = 4), and the data are presented as
mean ± standard deviation (SD) unless of otherwise stated. Statistical analysis was carried
out by means of one-way analysis of variance (ANOVA) with Tukey’s post hoc test. The
confidence levels of 95% (p<0.05) and 99% (p<0.01) were used and no adjustments were
made for multiple comparisons.
3. Results and discussion
Polycaprolactone (PCL) films with gelatin-coupled poly(glycidyl methacrylate) (P(GMA))
brushes were prepared via the following reaction sequence (Fig. 1): (a) active amine groups
were introduced to the PCL film surfaces by the aminolysis reaction, (b) the immobilization
of an alkyl bromide ATRP initiator was achieved via TEA-catalyzed condensation reaction
between the amine groups on the aminolyzed PCL substrates and 2-bromoisobutyryl bro‐
mide (BIBB), (c) well-defined P(GMA) functional brushes were covalently grafted from the
ATRP initiator-immobilized PCL surface via surface-initiated ATRP of GMA, (d) cell-adhe‐
sive gelatin was directly coupled to the pendant active epoxide groups of the grafted
P(GMA). Details of each functionalization step are discussed below.
Figure 1. Schematic illustration of the process of (a) aminolysis of PCL substrates to introduce the free amino groups
(the PCL-NH2 surface), (b) immobilization of a alkyl bromine-containing initiator via condensation reaction to give the
PCL-Br surface, (c) surface-initiated atom transfer radical polymerization (ATRP) of GMA from the PCL-Br surface to
produce the PCL-g-P(GMA) surface, and (d) subsequently covalent conjugation of gelatin to obtain the PCL-g-P(GMA)-
c-gelatin surface.
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3.1. Aminolysis of PCL substrates and immobilization of ATRP initiator
Aminolysis represents an easy-to-perform chemical technique to engraft amino groups
along the polyester chains, and hence has been widely used in the surface modification of
scaffolds for tissue engineering applications [31,34]. In this study, PCL substrates were acti‐
vated by the aminolysis reaction to introduce active amine groups. The relative amount of
amine groups on the aminolyzed PCL (defined as the PCL-NH2) surface was quantitatively
determined by XPS measurements. The [N]/[C] ratio, as determined from sensitivity factor-
corrected N 1s and C 1s core-level XPS spectral area, increases with the aminolysis time and
reaches the maximal value after 1 h, which is estimated to be about 0.043 (Figs. 2). The result
is consistent with the data reported previously [35,36]. As a degradation reaction, the ami‐
nolysis reaction is found to proceed preferentially at the amorphous regions of polymer in
diamine solution during the initial period [37]. At longer aminolysis time, the decrease in
bound amine groups may be caused by chain scission, formation of oligomers and other low
mass fragments that are removed from the surface during reaction and the rinsing process
[38]. Thus, the optimal aminolysis time for PCL film was found to be 1 h, and this reaction
time was chosen for the subsequent surface modification and cell studies.
Figure 2. The [N]/[C] ratio of the aminolyzed PCL surface as a function of aminolysis time determined by XPS measure‐
ments. The analysis reaction of PCL films proceeded at 40oC in 10 wt% 1,6-hexanediamine/2-propanol solution. Error
bars represent the standard deviation over separate measurement on three PCL films. The optimized aminolysis time
was observed at 1 h with the [N]/[C] ratio of 0.043.
The chemical composition of the PCL film surfaces at various stages of surface modification
was ascertained by XPS. Figs. 3a-3c show the respective wide scan, C 1s, and N 1s core-level
spectra of the pristine PCL and PCL-NH2 surfaces from 1 h of aminolysis. The C 1s core-lev‐
el spectra of the pristine PCL can be curve-fitted into three peak components with binding
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energies (BEs) at about 284.6, 286.2 and 288.7 eV, attributable to the C-H, C-O, and O=C-O
species, respectively (Fig. 3b) [39]. The area ratio of [C-H]:[C-O]:[O=C-O] is around
5.0:1.1:1.0 (Table 1), which is in good agreement with the theoretical value of 5:1:1 for the
polycaprolactone structures. The appearance of N 1s signal in the wide scan spectrum (Fig.
3a) and an additional peak component at 285.5 eV, attributable to C-N species, in the curve-
fitted C 1s core-level spectrum (Fig. 3c) indicate the successful introduction of amine groups
onto the PCL substrates after 1 h of aminolysis. The only peak component found at the BE of
399.6 eV in the N 1s core-level spectrum is associated with the free amine group on the PCL-
NH2 film surface (Fig. 3c') [38]. The decrease in static water contact angles of the PCL sub‐
strates from 93 ± 2o to 66 ± 3o is consistent with the presence of amine groups on the PCL-
NH2 surface (Table 1). The amine groups on the aminolyzed PCL surface can not only
improve surface hydrophilicity, but also offer the active sites for further functionalization.
Figure 3. Wide scan and C 1s core-level curve-fitted XPS spectra of the (a,b) pristine PCL, (c,d) PCL-NH2 from 1 h of
aminolysis, and (e,f) PCL-Br surfaces. Insets of (d') and (f') correspond to the N 1s and Br 3d core-level XPS spectra of
the PCL-NH2 and PCL-Br surfaces, respectively.
The immobilization of a uniform monolayer of initiators on the solid surface is indispensible
in the surface-initiated ATRP process [40]. An alkyl bromide ATRP initiator was introduced
onto the PCL-NH2 surface via TEA-catalyzed condensation reaction to produce the PCL-Br
surface. Successful introduction of the alkyl bromide-containing ATRP initiator onto the
PCL substrates can be deduced from the appearance of three additional signals with BEs at
about 70, 189 and 256 eV, attributable to Br 3d, Br 3p, and Br 3s, respectively, in the wide
scan spectrum of the PCL-Br surface (Fig. 3a) [41]. The [Br]/[C] ratio, as determined from the
Br 3d and C 1s core-level spectral area ratio, was about 3.17×10-2 (Fig. 3d). The correspond‐
ing Br 3d core-level spectrum of the PCL-Br surface with a Br 3d5/2 BE of 70.4 eV is consistent
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with the presence of the alkyl bromide species [41] (Fig. 3d'). The alkyl bromide-immobi‐
lized PCL surface became more hydrophobic, as static water contact angle increased noticea‐
bly to 85 ± 3o (Table 1).
Sample GYg(μg/cm2)
( mean± SDh)
[Br]/[C]i [N]/[C]i Surface compositionj
(molar ratio)
WCAk
(degree)
Pristine PCLa – – – [C-H]:[C-O]:[O=C-O]
= 5:1.1:1.0 (5:1:1)
93±2
PCL-NH2 b – – 0.043 [C-H]:[C-N]:[C-O]:[O=C-O]
= 4.7:0.7:1.1:1.0
66±3
PCL-Brc – 3.17×10-2 – [C-H]:[C-N]:[C-O/C-Br]:[O=C-O] =
5.0:0.9:1.7:1.0
85±3
PCL-g-P(GMA)1d 6.31±1.32 9.29×10-3 – [C-H]:[C-O]:[O=C-O]
= 3.8:2.8:1.0 (3:3:1)
62±4
PCL-g-P(GMA)2e 14.76±2.63 4.72×10-3 – [C-H]:[C-O]:[O=C-O]
= 3.1:3.0:1.0 (3:3:1)
61±5
PCL-g-P(GMA)1-c-
gelatinf
2.63± 0.52 – 0.169 [C-H]:[C-N]:[C-O]:[O=CNH]: [O=C-
O] = 3.5:1.5:1.7:1.0:0.7
37±3
PCL-g-P(GMA)2-c-
gelatinpala
3.79±0.73 – 0.203 [C-H]:[C-N]:[C-O]:[O=CNH]: [O=C-
O] = 3.1:1.5:1.4:1.0:0.3
35±4
a Pristine PCL refers to the cleaned PCL film after rigorous wasing with alcohol/water solution and deionized water, b
PCL-NH2 was obtained after 1 h of aminolysis in a 10% (w/w) 1,6-hexanediamine/isopropanol solution at 40 oC, c PCL-
Br was obtained after the PCL-NH2 surface reacted with 2-bromoisobutyryl bromide (BIBB) in dried hexane containing
1:1 (molar ratio) BIBB and triehtylamine (TEA), d,e Reaction conditions: [GMA]:[CuBr]:[CuBr2]:[bpy]=100:1:0.2:2 in meth‐
anol-water solution (1:1, v:v) at room temperature for 1 and 3 h to produce the PCL-g-P(GMA)1 and PCL-g-P(GMA)2
surfaces, respectively, f Reaction conditions: the PCL-g-P(GMA)1 and PCL-g-P(GMA)2 surfaces incubated in PBS (pH 7.4)
solution containing the gelatin at a concentration of 3 mg/mL at room temperature for 24 h, g GY denotes the graft‐
ing yield, and is defined as GY = (Wa - Wb)/A, where Wa and Wb corresponds to the weight of the dry films before and
after grafting of polymer brushes, respectively, and A is the film area (about 3.2 cm2
), h SD denotes standard deviation, i Determined from the corresponding sensitivity factor-corrected element core-level
spectral area ratios, j Determined from the curve-fitted C 1s core-level spectra. Theoretical values are shown in paren‐
theses. k WCA denotes static water contact angles.
Table 1. Grafting yield, surface composition, and water contact angles of the pristine PCL and surface-functionalized
PCL surfaces
3.2. Surface-initiated ATRP of GMA and immobilization of gelatin
P(GMA) is an effective surface linker to immobilize biomolecules, such as proteins, antibod‐
ies or enzymes, for tissue engineering applications [42]. Fig. 4 shows the respective wide
scan, C 1s and Br 3d core-level spectra of the PCL-g-P(GMA) surface from 1 and 3 h of ATRP
reaction. The C 1s core-level spectra of the PCL-g-P(GMA) surface can be curve-fitted into
three peak components with BEs at 284.6, 286.2 and 288. 7 eV, attributable to C-H, C-O and
O=C-O, respectively (Figs. 4b and 4d). For the PCL-g-P(GMA)1 surface from 1 h of ATRP,
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the area ratio of [C-H]:[C-O]:[O=C-O] is about 3.8:2.8:1.0 (Table 1), which is slightly different
from the theoretical value of 3:3:1 for the GMA unit structure. The deviation in peak compo‐
nent area ratio of C 1s core-level spectrum of the PCL-g-P(GMA)1 surface suggests that the
thickness of the P(GMA) brushes is less than the probing depth of XPS technique (about 8
nm in an organic matrix) [41]. Increasing the reaction time to 3 h leads to a [C-H]:[C-O]:
[O=C-O] ratio of about 3.1:3.0:1.0, which is close to the theoretical value of the GMA repeat
unit structure (Table 1). This is an indication that the P(GMA) brushes were thicker than the
probing depth of XPS technique. It has been reported that the thickness of the P(GMA)
brushes grafted on the silicon surface is around 30 nm after 3 h of ATRP of GMA under sim‐
ilar reaction conditions [41]. The presence of P(GMA) brushes leads to decrease in static wa‐
ter contact angles to 62 ± 4o and 61 ± 5o, respectively, for the PCL-g-P(GMA)1 and PCL-g-
P(GMA)2 surfaces, owing to the presence of hydrophilic epoxide groups [43].
Figure 4. Wide scan, C 1s, and Br 3d core-level curve-fitted XPS spectra of the (a,b,b') PCL-g-P(GMA)1 from 1 h of ATRP
reaction and (c,d,d') PCL-g-P(GMA)2 from 3 h of ATRP reaction. Successful grafting of P(GMA) polymer brushes can be
deduced from the area ratios of [C-H]:[C-O]:[O=C-O] peak components comparable to the theoretical value of 3:3:1 of
GMA molecular structure.
The grafting yield (GY) was measured to evaluate the kinetics of polymer chain growth in
this study. As shown in Fig. 5, an approximate linear increase in GY of the grafted P(GMA)
chains with polymerization time could be observed for the PCL-Br surface. The result sug‐
gests that the chain growth from the PCL-Br surface proceeds in a controlled and well-de‐
fined manner. The GY values of the PCL-g-P(GMA)1 and PCL-g-P(GMA)2 surfaces are
about 6.31 ± 1.32 and 14.76 ± 2.63 μg/cm2 (Table 1), respectively. The persistence of the Br 3d
core-level signal (Figs. 4b' and 4d') is consistent with the fact that the living chain end from
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the ATRP process involves a dormant alkyl halide group, which can be readily reactivated
to initiate the block copolymerization [25]. However, the molecular weight and molecular
weight distribution of the surface-graft polymers cannot be determined with sufficient accu‐
racy without precise cleavage of the grafted P(GMA) from the film surfaces [27].
Figure 5. A linear relationship between the grafting yield (GY) of the P(GMA) brushes with the surface-initiated ATRP
time. The polymer chain growth was tuneable by varying reaction time.
Nucleophilic reactions involving –NH2 moieties of biomolecules and the pendant epoxide
groups have been widely reported [44]. In this work, cell-adhesive gelatin was directly cou‐
pled to the pendant epoxide groups of the PCL-g-P(GMA)1 and PCL-g-P(GMA)2 surfaces to
produce the corresponding PCL-g-P(GMA)1-c-gelatin and PCL-g-P(GMA)2-c-gelatin surfa‐
ces, respectively. Fig. 6 shows the respective wide scan, C 1s and N 1s core-level spectra of
the gelatin-immobilized PCL surfaces. The corresponding curve-fitted C 1s core-level spec‐
trum was composed of five peak components with BEs at about 284.6, 285.5, 286.2, 288.2 and
289.1 eV, attributable to the C-H, C-N, C-O, O=CNH, and O=C-O species [41], respectively
(Figs. 6b and 6d). The C-N peak component is associated with the linkages in gelatin itself,
as well as the linkage between P(GMA) and gelatin. The O=CNH peak component is ascri‐
bed to the peptide bonds in gelatin. The above results and the appearance of a strong N 1s
signal with BE at 399.6 eV (Figs. 6b' and 6d'), characteristic of amine species, are consistent
with the fact that gelatin has been covalently immobilized on the P(GMA) brushes. The sur‐
face wettability of the PCL substrates is significantly improved after the immobilization of
gelatin, as water contact angles decrease to 37 ± 2o (for the PCL-g-P(GMA)1-c-gelatin) and 35
± 3o(for the PCL-g-P(GMA)2-c-gelatin) (Table 1). It is reported that gelatin contains large
amount of glycine (Gly) and proline (Pro) which are hydrophilic amino acids [45]. The hy‐
droxyl groups (-OH) generated in the ring-opening reaction of epoxide groups by coupling
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of gelatin could have also contributed to the lower water contact angle of the PCL-g-
P(GMA)-c-gelatin surfaces.
Figure 6. Wide scan, C 1s and N 1s core-level curve-fitted XPS spectra of the (a,b,b') PCL-g-P(GMA)1-c-gelatin and
(c,d,d') PCL-g-P(GMA)2-c-gelatin surfaces. The appearance of two additional peak components of C-N and O=CNH as
a result of immobilized gelatin.
3.3. Surface topography
The changes in topography of the PCL film surfaces after each functionalization step were
investigated by AFM. Fig. 7 shows the representative AFM height images of the pristine
PCL and functionalized PCL surfaces with scanned areas of 10 μm × 10 μm. The pristine
PCL film surface is relatively uniform and smooth with a root-mean-square surface rough‐
ness values (Ra) of about 19 nm (Fig. 7a). After the aminolysis treatment, the Ra value in‐
creases to 31 nm (Fig. 7b). The observation that aminolysis caused a noticeable increase in
surface roughness is in agreement with the findings by other groups [30,35]. The existence of
shallow pits is probably the result of the penetration of hexanediamine molecules into the
PCL films, since it has been previously reported that the aminolysis reaction can take place
at a depth of around 50 μm [23,30]. After graft polymerization of GMA, obvious increases in
Ra values are observed on the PCL-g-P(GMA)1 (56.9 nm, Fig. 7c) and PCL-g-P(GMA)2 surfa‐
ces (67.8 nm, Fig. 7e), and characteristic fiber-like features of polymer brushes are also visi‐
ble on the P(GMA)-grafted film surfaces (Figs. 7c and 7e). The subsequent coupling of
gelatin to P(GMA) brushes resulted in a further slight increase in surface roughness of PCL
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substrates, as Ra values increase to 59 nm and 71.5 nm for the PCL-g-P(GMA)1-c-gelatin and
the PCL-g-P(GMA)2-c-gelatin surfaces, respectively.
Figure 7. Representative two-dimensional (2D) AFM images of (a) pristine PCL, (b) PCL-NH2, (c) PCL-g-P(GMA)1 from 1
h of ATRP, (d) PCL-g-P(GMA)2 from 3 h of ATRP, (e) PCL-g-P(GMA)1-c-gelatin, and (f) PCL-g-P(GMA)2-c-gelatin surfa‐
ces. The arithmetical mean roughness (Ra) of different PCL substrates was obtained from a scan size of 10 μm × 10 μm.
3.4. Endothelial cells proliferation and surface endothelialization
The adhesion and proliferation of endothelial cells (ECs) on the functionalized PCL surfaces
was quantitatively determined by the AlamarBlueTM (AB) assay, and the results are shown
in Fig. 8. The pristine PCL film surface is the least conducive for supporting cellular growth,
since only a marginal increase in cells over 7 days of culture was observed. The cells attach‐
ed to the PCL-NH2 film surfaces showed a slight improvement in proliferation as compared
to the pristine PCL surface. This result is consistent with previous findings that the presence
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of amine groups on the PCL surfaces leads to a positive effect on cell proliferation [23,30],
albeit to a limited extent. Despite the improvement in surface hydrophilicity and roughness,
the grafting of P(GMA) brushes onto the PCL film surfaces did not lead to an enhancement
in EC proliferation behavior, which is probably associated with the cytotoxicity and mutage‐
nicity of epoxides groups to ECs [46]. Besides the fact that polymer surfaces with moderate
hydrophilicity of water contact angles in a range of 30-70o and rougher nano-topography are
favorable for cell attachment and proliferation [47,48], other factors (e.g. biological cues)
may also be required for positive cell interaction with material substrates. This hypothesis
was confirmed by the observation that the gelatinized P(GMA)-grafted PCL substrates ex‐
hibited higher affinity and proliferation for ECs as compared to the surfaces that did not
contain the bioactive gelatin motifs.
In fact, the proliferation rates of the PCL-g-P(GMA)1-c-gelatin and PCL-g-P(GMA)2-c-gelatin
surfaces were comparable to that of the gelatin-coated coverslips (positive controls). Cell prolif‐
eration on the gelatin-immobilized PCL surfaces was not only significantly enhanced, but also
found to be positively correlated to the amounts of immobilized gelatin. The PCL-g-P(GMA)2-
c-gelatin surface exhibited more pronounced enhancement in cell adhesion and proliferation
than that of the PCL-g-P(GMA)1-c-gelatin surface, as the longer ATRP reaction time allowed for
more gelatin to be attached. This result suggests that an increase in surface density of the immo‐
bilized gelatin can lead to an increase in EC proliferation over time. This phenomenon is proba‐
bly associated with the fact that immobilization of gelatin provides many epitopes or ligands
for cell adhesion molecules, such as integrins, thus mimicking the natural extracellular environ‐
ment that is favorable for EC adhesion, spreading and proliferation.
Figure 8. EC proliferation profile on the gelatin-coated coverslips, pristine PCL and functionalized PCL surfaces after 1,
3, 5 and 7 days of incubation at 37 oC in a 5% CO2 atmosphere as determined by the AlamarBlueTM(AB) assay. Data
presented as means ± SD. *p<0.05 and **p<0.01 refers to statistically significant difference compared with the pristine
PCL surface. The cell proliferation rate of ECs seeded on the gelatin-immobilized surfaces was significantly improved as
compared to that the pristine PCL film.
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The visualization of EC coverage on the functionalized PCL surfaces enabled a good assess‐
ment of the efficacy of endothelialization over the entire surface. Fig. 9 shows the represen‐
tative fluorescence images of LIVE/DEAD-stained ECs on the pristine PCL and
functionalized PCL film surfaces after 7 days of culture. The sparse coverage of ECs on the
pristine PCL substrate further confirmed the unfavorable surface properties of pristine PCL
for cell adhesion and proliferation (Fig. 9b). Poor endothelialization was also observed on
the aminolyzed PCL (Fig. 9c) and P(GMA)-grafted PCL surfaces (Fig. 9d). The dense growth
of ECs on the PCL-g-P(GMA)1-c-gelatin (Fig. 9e) and PCL-g-P(GMA)2-c-gelatin (Fig. 9f) sur‐
faces indicated significant improvement in EC coverage for the gelatin-immobilized PCL
surfaces. The observed denser coverage of ECs on the PCL-g-P(GMA)2-c-gelatin surfaces
compared to the PCL-g-P(GMA)1-c-gelatin surfaces meant that the efficacy of endotheliali‐
zation is positively correlated to the amount of immobilized gelatin. Taken together, the re‐
sults suggest that the higher the surface concentration of immobilized gelatin, the better the
endothelialization efficacy of the material within a given period of time.
Figure 9. Fluorescence images of LIVE/DEAD-stained ECs on the (a) gelatin-coated coverslips (positive control), (b)
pristine PCL, (c) PCL-NH2, (d) PCL-g-P(GMA)2, (e) PCL-g-P(GMA)1-c-gelatin, and (f) PCL-g-P(GMA)2-c-gelatin after 7
days of incubation in cell suspension (2×104 cells/ml). Scale bar: 20 μm. Rapid endothelialization was observed for the
gelatin-immobilized PCL surfaces.
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3.5. Blood compatibility tests
3.5.1. Hemolysis rate test
Hemolysis rate is an important factor for characterization of the blood compatibility. The
lower the hemolysis rate, the better the blood compatibility. Figure 10 shows the hemolysis
rate of the pristine PCL and surface-functionalized PCL samples. It can be seen that the he‐
molysis rate of the functionalized samples has no substantial improvement. The gelatin-im‐
mobilized PCL substrates even show a relatively higher hemolysis rate than those of the
pristine PCL and PCL-NH2 surfaces. This result is consistent with the previous findings that
gelatin exhibited somewhat hemostatic effect by nature. However, the hemolysis rate of the
gelatin-immobilized PCL samples is approximately 3%, far below the accepted threshold
value of 5% for biomaterial applications. Thus, the gelatin-immobilized samples can be used
as a novel material with good hemocompatibility.
Figure 10. Hemolysis rate of the pristine PCL and surface-functionalized PCL samples. Data presented as means ± SD,
n=3.
3.5.2. Coagulation activity on the bare and endothelialized PCL substrates
Blood coagulation, particularly under conditions of relatively low flow, has been recognized
to be one of the main problems of vascular occlusion [49]. Activated coagulation factors in‐
fluence the clotting time through extrinsic, intrinsic and common coagulation pathways.
Prothrombin time (PT) is used to evaluate deficiencies in the extrinsic factor, and represents
the time for blood plasma to clot after the addition of thromboplastin (activator of the extrin‐
sic pathway) [50]. Activated partial thromboplastin time (APTT) is used to evaluate the in‐
trinsic factors, such as VIII, IX, XI and XII, and common coagulation pathway factors V, X
and II [50]. Both PT and APTT are commonly used to screen for adverse activation of the
coagulation pathways on the vascular grafts and to evaluate their haemocompatibility in vi‐
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tro. Thus, the PT and APTT values of the bare and endothelialized PCL substrates with vari‐
ous surface modifications were measured.
Figure 11. a) PT and (b) APTT results (means ± SD, n=3) for the bare and endothelialized surfaces of pristine PCL and
surface-functionalized PCL, The coagulation activity of all surfaces was found to be in the normal range for healthy
blood plasma.
The normal ranges of PT and APTT for healthy blood plasma are 12.0-14.5 s and 27.0-35.6 s,
respectively [51]. Fig. 11 shows the PT and APTT results for the bare and endothelialized
PCL substrates with various surface modifications. For the bare PCL and functionalized
PCL surfaces, both PT and APTT are all within the normal ranges of coagulation time. None
of the PCL substrates was found to affect the coagulation pathways significantly, and no
discernible effect was observed in the presence of gelatin, indicating that surface functionali‐
zation activated neither the intrinsic nor the extrinsic coagulation pathways. This result is
consistent with previous findings by other groups that cell-adhesive proteins and peptides
do not affect or convert blood coagulation pathways [51,52]. Even after the PCL substrates
were coated with a layer of ECs, the PT and APTT readings were still observed to be in the
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normal range of the clinical reference, and no significant differences in the coagulant activi‐
ties were observed on the endothelialized PCL substrates as compared to the bare PCL sub‐
strates. The results also revealed that the ECs cultured on the pristine PCL and
functionalized PCL surfaces remained unactivated and did not exhibit procoagulation phe‐
notypes. Hence, it could be concluded that the presence of the monolayer of ECs had no ef‐
fect on the intrinsic or the extrinsic coagulation pathways.
3.5.3. Nitric Oxide (NO) production
Nitric oxide (NO) is an important regulator of vascular tone and platelet adhesion and the
continuous NO release by ECs prevents thrombogenesis [53]. In this study, the NO secretion
of the ECs on the pristine PCL and functionalized PCL surfaces were measured. As shown
in Fig. 12, the amount of NO secreted by ECs on the gelatin-immobilized PCL surfaces was
significantly higher than those on the pristine PCL, aminolyzed and P(GMA)-grafted PCL
surfaces. The amount of NO production of the ECs seeded on the PCL-g-P(GMA)2-c-gelatin
surface was around 2-fold higher than that on the PCL-g-P(GMA)1-c-gelatin surfaces, indi‐
cating that the improved NO production observed for ECs grown on the gelatin-immobi‐
lized PCL surface may be positively correlated to the amount of covalently immobilized
gelatin. The above results suggest that a high density of immobilized gelatin led to the en‐
hancement in NO secretion.
Figure 12. The amount of NO production for the ECs seeded on the pristine and functionalized PCL substrates. Data
presented as means ± SD, n=3. *p<0.05 and **p<0.01 corresponds to statistically significant difference as compared to
the pristine PCL.
3.5.4. Platelet activation on the bare and endothelialized PCL substrates
Apart from coagulation pathways, platelet activation is considered another important crite‐
rion in assessing blood compatibility of the biomaterial surface. The activation of attached
platelet results in platelet aggregation and the formation of a thrombus [54]. The subendo‐
Advances in Biomaterials Science and Biomedical Applications196
thelial collagens (i.e., types I - IV) have been found to interact directly with platelets to trig‐
ger their activation for thrombogenic initiation [55]. As gelatin is a derivative of collagen,
one downside of using gelatin-immobilized surfaces could be the detrimental adhesion and
activation of platelets, which could initiate clotting. Therefore, the extent of platelet activa‐
tion by the different biomaterial surfaces was studied.
Figure 13. P-selectin expression for the (a) bare and (b) endothelialized surfaces of the pristine and functionalized PCL
substrates. Plasma rich platelet (PRP) was used as positive control. *p<0.05 and **p<0.01 corresponds to statistically
significant difference compared with the pristine PCL surface.
In this study, platelet activation on the bare and endothelialized PCL substrates was de‐
termined using the P-selectin assay, since P-selectin is one of intracellular granular mole‐
cules released upon platelet  activation and stimulation [5],  For the bare PCL substrates,
the amount of activated platelets on the gelatin-immobilized PCL surfaces was compara‐
ble  to  those  of  the  pristine  PCL surfaces  (Fig.  13a).  In  contrast,  platelet  activation  was
found to be significantly higher on the P(GMA)-grafted PCL surfaces, indicative of an in‐
creased risk for thrombogenesis. The results suggest that the immobilization of gelatin on
the P(GMA)-grafted PCL surfaces not only rendered them with adhesion-promoting prop‐
erties,  but also decreased the risk of  inducing the activation of platelets.  It  has been re‐
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ported previously that the biological motifs immobilized on the polymers could not bind
effectively with the platelet integrin unless their separation distances was between 1.48-2.2
nm [56], and that polymers with small spacer, such as lauric acid-conjugated GRGDS, ex‐
hibited no increase in activation [57].  Here,  the gelatin was directly conjugated onto the
grafted P(GMA) brushes (small spacer), and thus the gelatin motif could not gain access
to the binding sites of the platelet integrin (such as α2β1). In addition, it is probable that
the  other  surface  properties  (e.g.  enhanced hydrophilicity)  were  also  responsible  for  re‐
duced platelet activation activity.
In the case of the endothelialized PCL substrates, the amount of activated platelets on the
gelatin-immobilized PCL surfaces was significantly reduced with respect to the other endo‐
thelialized PCL substrates (Fig. 13b), indicative of good anti-thrombogenic behavior of the
EC confluent layer. This result is consistent with the high level of NO production by ECs on
the gelatinized PCL surface. The P-selectin expression on the endothelialized pristine PCL
and PCL-NH2 surfaces was higher than those on the bare substrates (Fig. 13b), which is line
with the well-established fact that subconfluent EC layers were more thrombogenic in na‐
ture [13]. The platelet activation was significantly enhanced on the endothelialized P(GMA)-
grafted PCL surfaces, as observed by the high levels of P-selectin expression, which is an
indication of an increased risk of thrombogenesis for those surfaces. Overall, the above re‐
sults showed that the thrombogenicity of a biomaterial is influenced by both EC confluency
and the surface properties of the biomaterial. Consequently, it can be concluded that the im‐
mobilization of gelatin on the P(GMA) brushes prevented platelet activation, but that the
presence of the P(GMA) brushes alone led to a pro-thrombogenic surface.
3.5.5. Expression and activity of vWF and MMP-2 of EC on the surface-functionalized PCL samples
In order to further investigate the thrombogenicity of endothelialized surfaces, we per‐
formed real-time PCR tests and protein immunoblotting on factors that mediate platelet ad‐
hesion to ECs. The expression of von Willebrand factor (vWF) on endothelial cells promotes
platelet adhesion and high or abnormal expression of vWF has been implicated in pathologi‐
cal conditions such as thrombosis [58]. Matrix metalloproteinase-2 (MMP-2) is another factor
known to be involved in platelet aggregation, as well as to have important roles in the deg‐
radation and remodeling of the endothelial extracellular matrix [59, 60]. 7 days after the
seeding of ECs, the relative expression of both vWF and MMP-2 mRNA in the EC on both
PCL-g-P(GMA)1-c-gelatin and PCL-g-P(GMA)2-c-gelatin surfaces were downregulated
when compared to the ECs on PCL-g-P(GMA) surfaces and gelatin-coated coverslips (Fig.
14a and 14c). Immunoblotting of the vWF protein produced in ECs, also, suggest that it is
lower in ECs on PCL-g-P(GMA)- c-gelatin surfaces in comparison to PCL-g-P(GMA) surfa‐
ces but differed where the vWF expression of ECs on the pristine PCL surface and gelatin-
coated coverslip could not be detected (Fig. 14b). Nevertheless, these results suggest that
pro-thrombogenic factors could be increased on bare PCL-g-P(GMA) surfaces and the conju‐
gation of gelatin could help to reduce thrombogenicity.
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Figure 14. Real-time qPCR revealed that the expression of (a) vWF and (c) MMP-2 in ECs on PCL-g-P(GMA)-c-gelatin
surfaces is lower when compared to PCL-g-P(GMA) surfaces and gelatin-coated coverslips. Expression levels are nor‐
malized using the housekeeping gene rpl27 and taken relative to ECs on pristine PCL (dotted line) (mean ± SD, n=3).
Endothelial cells treated with TNF-αfor 6 h were used as a positive control for the expression of both genes. (c) Immu‐
noblotting of vWF protein expressed in ECs on PCL-g-P(GMA)-c-gelatin is also reduced when compared to PCL-g-
P(GMA) surfaces, thus corroborating the real-time PCR results.
4. Conclusion
This study described the successful biofunctionalization of PCL substrates with tunable sur‐
face densities of covalently-immobilized gelatin by surface-initiated ATRP of glycidyl meth‐
acrylate (GMA). Kinetics studies revealed that the grafting yield of the functional P(GMA)
brushes increased linearly with polymerization time, and the amount of immobilized gelatin
increased with the concentration of epoxide groups on the P(GMA) brushes. The significant
improvement in the adhesion and proliferation of ECs on the gelatin-immobilized PCL sub‐
strates were found to be positively correlated to the amount of covalently immobilized gela‐
tin. Blood compatibility tests demonstrated that the ECs cultured on the gelatin-
immobilized-P(GMA) surfaces exhibited low platelet activation and significantly increased
nitric oxide (NO) production, although the coagulation pathways were not affected both be‐
fore and after EC coverage. Overall, the high surface-density of immobilized gelatin ob‐
tained by surface-initiated ATRP on the PCL surfaces is favorable for EC attachment and
proliferation. The attached ECs maintained an unactivated and non-thrombogenic pheno‐
type that mimics the EC lining of a healthy blood vessel. Hence, such a surface may have
huge potential for vascular graft applications.
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